A bipartisan group of U.S. senators have introduced a bill to promote research into the therapeutic potential psychedelics by creating a new office in the Department of Veterans Affairs (VA) that would advance the development innovative treatments for serious mental health conditions and assist in reviewing the scheduling status of drugs like psilocybin, ibogaine and MDMA.
The legislation—titled the “Veterans Health Administration Novel Therapeutics Preparedness Act”—is being led by Sen. Tim Sheehy (R-MT) and is cosponsored by Sens. Tammy Duckworth (D-IL), Ruben Gallego (D-AZ) and John Boozman (R-AR).
“After young Americans who signed up to fight for our nation and were willing to give up their own lives for others come home, we better make sure the VA is ready to care for them and that they have access to the best, most innovative care available,” Sheehy said in a press release. “The VA’s core mission is to care for veterans, and this bipartisan bill will help the hardworking men and women at the VA fulfill that critical mission.”
If enacted, the new bill would direct the VA to take steps to streamline studies into psychedelics and other emerging therapies
This is one of the latest examples of congressional efforts
Read full article on Marijuana Moment
